Clinical Trials Browser

Phase 2/3 × Interventional × Thrombopoietin × Clear all

NCT01319669 2017-03-03

Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung